TCTAP C-235 An Old Man Needed 3 Stent Grafts to Fix Critical Aortic Stenosis and Transsubclavian Vascular Access Complication  by Yu, Ho-Ping & Yin, Wei-Hsian
C
A
S
E
S
19th CardioVascular Summit: TCTAP 2014Case Summary:
This 65 year old man had successful TAVI with a 29mm Medtronic CoreValve for
severe symptomatic aortic stenosis. Aortic annular size of 24mm was derived from
perimeter measurements of the annulus manually using multiplanar reconstruction of
0.6mm size multidetector computed tomography (MDCT) images. The choice of
bioprosthetic valve was based on the size of his aortic annulus, and also on the
possibility that the patient may require a valve-in-valve procedure in future given his
dialysis-dependent chronic renal failure.
Unfortunately the patient re-presented 22 months post TAVI with severe symptomatic
aortic stenosis. The CoreValve was found to be under-deployed with extensive
calciﬁcation on MDCT. The patient proceeded to surgical aortic valve replacement.
Based on this case we recommend routine acquisition of orthogonal ﬂuoroscopic
views for conﬁrmation of complete valve deployment during TAVI, as well as
aggressive management of parathyroid hormone dysfunction in patients with dialysis-
dependent renal failure undergoing TAVI.
TCTAP C-235
An Old Man Needed 3 Stent Grafts to Fix Critical Aortic Stenosis and
Transsubclavian Vascular Access Complication
Ho-Ping Yu, Wei-Hsian Yin
Cheng-Hsin General Hospital, Taiwan
[Clinical Information]
Patient initials or identiﬁer number:
9389758
Relevant clinical history and physical exam:
83 years old man
A case of symptomatic severe aortic stenosis with high surgical risk (Logistic Euro-
Score 23%)
Co-morbidities: COPD, BPH, Chyluria
Relevant test results prior to catheterization:
Transthoracic Echocardiography
 Preserved LV & RV systolic function
 Severely calciﬁed & degenerated trileaﬂet aortic valve
 Critical aortic stenosis w 0.6cm2 by continuity equation
 Aortic valve pressure gradient (peak w 87mmHg, mean w 56mmHg)
 Moderate aortic regurgitation
 Moderate mitral regurgitation
 Moderate tricuspid regurgitation (RVSP w 52mmHg)
CT angiography
 aortic annulus diameter 18.5x26.6mm,
 Severe disease of bilateral iliac arteries
[Interventional Management]
Procedural step:
Procedure: Transcatheter aortic valve implantation
Approach: Left subclavian artery (cut down)
Anesthesia: General
Devices: Ultimum introducer sheath 18F 30cm (St. Jude Medical)
Amplatz super stiff straight guidewire 0.035” 260cm (Boston scientiﬁc)
3rd generation CoreValve 29mm (Medtronic)
 Temporary pacemaker implantation in RV was done via right subclavian vein.
 5F pigtail catheter was placed in non-coronary sinus via right brachial artery
for supra-aortic angiogram.
 We ﬁrst crossed stenotic aortic valve with straight soft tip 0.035” guidewire
and 5F AL1 diagnostic catheter.
 Then we changed to 5F pigtail catheter into LV cavity and then changed to
Amplatz super stiff guidewire.
 CoreValve was advanced, carefully positioned and deployed across the ste-
notic aortic valve under rapid RV pacing.
 CoreValve was found to be very deep after partial deployment.
 We pulled back the delivery catheter and the CoreValve.
 The CoreValve was popped up into the ascending aorta.
 So, CoreValve & delivery catheter were withdrawn into the sheath and then
extracted.S210 JACC Vol 63/12/Suppl S j A new 29mm CoreValve was advanced, carefully positioned and deployed
across the stenotic aortic valve under rapid RV pacing.
 Aortography after deployment of CoreValve showed acceptable position.
 TEE after implantation of CoreValve showed minimal paravalvular leak.
 A large dissection ﬂap was seen in left subclavian artery after removal of 18F
sheath.
 Transection of left subclavian artery was happened during repair.
 Vascular forcep occluded the proximal stump of transected artery.
 A 0.035” 260cm guidewire was introduced via right common femoral artery
into left subclavian artery.
 Then the left subclavian artery was occluded with 8x40mm PTA balloon.
 Then 0.035” 260cm guidewire was introduced into the distal stump of
transected artery.
 Then shuttle sheath was advanced over the guidewire into the left axillary
artery.
 A 8x100mm Viabahn stent graft was deployed to connect the proximal stump
and the distal stump of transected artery exposing a few cm of naked stent
graft at subclavicular fossa.
 Angiography after stent graft showed good distal ﬂow and there was no
leakage of blood.April 22–25, 2014 j TCTAP Abstracts/CASE/Valvular Heart Disease
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19th CardioVascular Summit: TCTAP 2014Vulnerable Plaque Diagnosis and Treatment
(TCTAP C-236)
TCTAP C-236
The Overlooked Lesion Made Repetitive No-ﬂow
Ying-Hsien Chen
National Taiwan University Hospital, Taiwan
[Clinical Information]
Patient initials or identiﬁer number:
LHM
Relevant clinical history and physical exam:
72 y/o woman with diabetes mellitus, hyperlipidemia, hypertension and left pons
ischemic stroke, had exertional angina off and on in past 2 months
Physical Examination: decrease right side muscle power, otherwise not remarkable.
Relevant test results prior to catheterization:
T-CHO 215 mg/dL, HDL 40 mg/dL, HbA1C: 5.4%, CRE: 0.8 mg/dL.
Thallium Scan: (1) signiﬁcant stress-induced ischemia mixed with scarred myocar-
dium, post-stress ¼ 44% (2) Regional Wall Motion: hypokinesia at apex. (3) Transient
stress-induced LV dilatation.
Relevant catheterization ﬁndings:
Signiﬁcant proximal LAD stenosis to 90-95% with patent LM.
Insigniﬁcant lesion over LCX and RCA.
[Interventional Management]
Procedural step:
We use 6FAL1 guiding catheter and pass SIONwire to distal LAD. Balloon angioplasty
was done with Sprinter Legend 2 X 15mm in order to fascilitate IVUS study. IVUS
examination with Boston Scientiﬁc Atlantis SR Pro 40 MHz showed vessel size to 3.5-
3.75 mm with attenuated plaques. Further balloon angioplasy was done with Abbott
TREK 3.5 X 15 mm. But acute no-ﬂow developed. We ﬁrst deployed Boston Scientiﬁc
Promus Element 3.5 X 32 mm but were unable to establish adequate coronary ﬂow.
Therefore, we administered IC nitroglycerin and tiroﬁban. TIMI 1-2 ﬂow was achieved
and stent edge dissection was noted. Further balloon angioplasy was done with Abbott
TREK 3.5 X 15 mm over the stent edge. Unfortunately, No-ﬂow developed again. This
time, we use Kaneka Thrombuster 6Fr for thrombosuction and also administered IC
adenosine and additional dose of heparin 2500 U. TIMI 3 ﬂow was achieved and stent
edge dissection remained. To cover the stent edge, another Boston Scientiﬁc Promus
Element 3.5 X 12 was implant which resulted in TIMI 3 ﬂow. To end up the procedure,
we performed ﬁnal IVUS examination. To our surprise, there was thrombus inside the
proximal stent. Immediate after IVUS study, no-ﬂow developed again. We use Kaneka
Thrombuster 6Fr for thrombosuction and aslo administered IC adenosine again. Fol-
lowed angiography showed TIMI 3 ﬂow, but one focal ﬁlling defect was noted inside the
proximal stent. In concerned of acute stent thrombosis, balloon angioplasy was done
with Abbott TREK 3.5 X 15 mm again with ﬁnal TIMI 3 ﬂow was achieved. She was
transfer to ICU and continued heparin and tiroﬁban treatment.JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/CASCase Summary:
The patient received the elective LAD PCI. To my suprise, a total of 4 episodes of no-
ﬂow developed during the procedure with peri-procedure MI. The procedure steps
need to be reconsidered again in order to prevent the complication from happening.E/Vulnerable Plaque Diagnosis and Treatment S211
